TheraDoc Introduces Clinical Decision Support Alert Bundles

TheraDoc Introduces Clinical Decision Support Alert Bundles

SALT LAKE CITY, July 22, 2009 - TheraDoc®, a leader in clinical informatics, today unveiled six new clinical and adverse drug event alert packages designed to help hospitals improve patient care and safety. The alert bundles, addressing a range of clinical areas and drug monitoring parameters, work with the TheraDoc Expert System Platform®, which provides ongoing electronic surveillance of patient data from multiple hospital information sources and alerts caregivers to clinically significant changes in patients' conditions.

The new packages contain from 27 to 55 alerts each and include:

•Patient Monitoring, which scrutinizes lab and admission data for out-of-range test results and shifts in a patient's condition.
•Therapeutic Drug Monitoring & Drug Utilization Monitoring, which track pharmacy and lab data about medications, such as dosage and drug selection, in order to optimize the clinical efficacy and benefit for each patient, as well as costs for hospitals.
•Adverse Drug Event Surveillance, which looks at patient, pharmacy, and lab data to help identify potential adverse drug events and intervene to prevent patient harm. It includes alerts to help automate many medication triggers from the Institute for Healthcare Improvement Global Trigger tool to increase medication safety.
•Toxicology, which monitors lab data for the presence or abnormal levels of potentially harmful substances.
•Anticoagulation, which addresses a recent Joint Commission National Patient Safety Goal and tracks compliance and the monitoring of patients receiving anticoagulation drug therapy.


The TheraDoc Expert System Platform and these new alert bundles help clinicians meet the challenges of today's complex clinical care environment in a targeted fashion and make enhanced patient safety achievable for any size hospital. The technology allows healthcare providers to better manage the growing torrent of medical information, increased time constraints, demands for accountability, and pressure to contain costs, while providing the highest level of patient care. The alert bundles also offer an affordable way for hospitals and clinics to start the journey toward the 2011 federal goals for meaningful use of health information technology, which focus on such areas as real-time access to medical information, clinical decision support to improve the quality and efficiency of care, and clinical documentation.

Michael Barton, Pharm.D., TheraDoc senior vice president of knowledge and product development, said the alert bundles-which are the result of years of development, testing, validation, and consultation with clinical experts-simplify the implementation process for hospitals. "Our customers have told us that they would benefit from the ability to select preconfigured alert bundles that address specific patient-care issues, initiatives, or quality measures," Barton said. "The alert bundles reflect TheraDoc's mission to help hospitals improve safety and productivity by taking full advantage of available information so they can intervene as quickly as possible to prevent and mitigate problems."

The TheraDoc Expert System Platform receives and standardizes patient data from multiple hospital information sources. With this platform in place, hospitals also can incrementally acquire any of the TheraDoc suite of Knowledge Modules, which includes the Infection Control Assistant®, Antibiotic Assistant®, ADE Assistant®, and Clinical Alerts Assistant®.

About TheraDoc
Founded in 1999, TheraDoc is a clinical informatics company dedicated to improving the quality, safety, and efficiency of patient care through enhanced clinical decision making. The company provides innovative products that improve clinical and financial outcomes for a range of provider and payer organizations, including leading healthcare providers Johns Hopkins, the National Institutes of Health, and Emory Healthcare. TheraDoc's leadership in medical informatics standards enables the exchange and use of information between disparate health information systems. The company's founders and core medical informatics team are internationally recognized for their pioneering and continuing work in clinical decision support design and development, which spans two decades. For more information, visit www.theradoc.com.

Suggested Articles

I-MAB's anti-GM-CSF drug works "upstream" in inflammation pathways, potentially blocking several dangerous cytokines in COVID-19, executives…

Antibe's lead drug beat placebo at reducing osteoarthritis pain, boosting its case as an alternative to NSAIDs, commonly used to treat the condition.

The trial marks the start of a new phase of the response to SARS-CoV-2 in which people will receive drugs designed specifically for the virus.